Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May 15;91(9):e65-7.
doi: 10.1097/TP.0b013e3182157d44.

Direct pathway T-cell alloactivation is more rapid than indirect pathway alloactivation

Shipra Gupta, Savithri Balasubramanian, Thomas B Thornley, Terry B Strom, James J Kenny

Direct pathway T-cell alloactivation is more rapid than indirect pathway alloactivation

Shipra Gupta et al. Transplantation. .
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(A) In comparison with CB6F1 donor skin grafts, there is a delay in rejection of BALB/c donor skin grafts by B6.TEa.Rag2−/− recipients (n≥4). (B) Delayed proliferation of B6.TEa.Rag2−/− CD4+ T cells when the alloantigen is presented by the indirect pathway (n=3).
See this image and copyright information in PMC

References

    1. Bolton EM, Bradley JA, Pettigrew GJ. Indirect allorecognition: Not simple but effective. Transplantation. 2008;85:667. - PubMed
    1. Gokmen MR, Lombardi G, Lechler RI. The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol. 2008;20:568. - PubMed
    1. Grubin CE, Kovats S, deRoos P, et al. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity. 1997;7:197. - PubMed
    1. Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med. 2006;203:1851. - PMC - PubMed
    1. Trambley J, Bingaman AW, Lin A, et al. AsialoGM1+ CD8+ T cells play a critical role in costimulation blockade–resistant allograft rejection. J Clin Invest. 1999;104:1715. - PMC - PubMed

Publication types